BACKGROUND: A comparison of patients with erythema migrans due to Borrelia garinii versus Borrelia burgdorferi has not been reported. PATIENTS AND METHODS: One hundred nineteen patients from New York State with erythema migrans caused by B. burgdorferi were compared with 116 patients from Slovenia with erythema migrans due to B. garinii infection. RESULTS: Patients with B. garinii infection were older, more often reported a tick bite, and developed larger lesions (median largest diameter: 18 and 14 cm, respectively; p = 0.01) that more often had central clearing (61.2% compared with 35.3%; p < 0.0001). Patients infected with B. burgdorferi, however, more often had systemic symptoms (68.9% vs. 37.1%; p < 0.0001), including fatigue (p < 0.0001), arthralgia (p = 0.0003), myalgia (p < 0.0001), headache (p = 0.0008), fever and/or chills (p < 0.0001), and stiff neck (p < 0.0001), and more often had abnormal physical findings (57.1% compared with 11.2%; p < 0.0001), such as fever (p = 0.0002) or regional lymphadenopathy (p < 0.0001). There was a trend for more patients with B. burgdorferi infection to have multiple erythema migrans skin lesions (13.4% compared with 5.2%; p = 0.051), and among patients with multiple erythema migrans the number of lesions was greater in B. burgdorferi-infected patients (median: 5.5 compared with 2.0; p = 0.006). CONCLUSIONS: The results of the present study indicate that in patients with erythema migrans the clinical features vary according to whether infection is caused by B. garinii or B. burgdorferi.
BACKGROUND: A comparison of patients with erythema migrans due to Borrelia garinii versus Borrelia burgdorferi has not been reported. PATIENTS AND METHODS: One hundred nineteen patients from New York State with erythema migrans caused by B. burgdorferi were compared with 116 patients from Slovenia with erythema migrans due to B. garinii infection. RESULTS:Patients with B. garinii infection were older, more often reported a tick bite, and developed larger lesions (median largest diameter: 18 and 14 cm, respectively; p = 0.01) that more often had central clearing (61.2% compared with 35.3%; p < 0.0001). Patients infected with B. burgdorferi, however, more often had systemic symptoms (68.9% vs. 37.1%; p < 0.0001), including fatigue (p < 0.0001), arthralgia (p = 0.0003), myalgia (p < 0.0001), headache (p = 0.0008), fever and/or chills (p < 0.0001), and stiff neck (p < 0.0001), and more often had abnormal physical findings (57.1% compared with 11.2%; p < 0.0001), such as fever (p = 0.0002) or regional lymphadenopathy (p < 0.0001). There was a trend for more patients with B. burgdorferi infection to have multiple erythema migrans skin lesions (13.4% compared with 5.2%; p = 0.051), and among patients with multiple erythema migrans the number of lesions was greater in B. burgdorferi-infected patients (median: 5.5 compared with 2.0; p = 0.006). CONCLUSIONS: The results of the present study indicate that in patients with erythema migrans the clinical features vary according to whether infection is caused by B. garinii or B. burgdorferi.
Authors: Allen C Steere; Franc Strle; Gary P Wormser; Linden T Hu; John A Branda; Joppe W R Hovius; Xin Li; Paul S Mead Journal: Nat Rev Dis Primers Date: 2016-12-15 Impact factor: 52.329
Authors: Bobbi S Pritt; Paul S Mead; Diep K Hoang Johnson; David F Neitzel; Laurel B Respicio-Kingry; Jeffrey P Davis; Elizabeth Schiffman; Lynne M Sloan; Martin E Schriefer; Adam J Replogle; Susan M Paskewitz; Julie A Ray; Jenna Bjork; Christopher R Steward; Alecia Deedon; Xia Lee; Luke C Kingry; Tracy K Miller; Michelle A Feist; Elitza S Theel; Robin Patel; Cole L Irish; Jeannine M Petersen Journal: Lancet Infect Dis Date: 2016-02-06 Impact factor: 25.071
Authors: Maria O'Rourke; Andreas Traweger; Lara Lusa; Dasa Stupica; Vera Maraspin; P Noel Barrett; Franc Strle; Ian Livey Journal: PLoS One Date: 2013-05-16 Impact factor: 3.240
Authors: Franc Strle; Gary P Wormser; Paul Mead; Kanthi Dhaduvai; Michael V Longo; Omosalewa Adenikinju; Sandeep Soman; Yodit Tefera; Vera Maraspin; Stanka Lotrič-Furlan; Katarina Ogrinc; Jože Cimperman; Eva Ružić-Sabljić; Daša Stupica Journal: PLoS One Date: 2013-05-30 Impact factor: 3.240
Authors: Franc Strle; Petra Bogovič; Jože Cimperman; Vera Maraspin; Katarina Ogrinc; Tereza Rojko; Daša Stupica; Lara Lusa; Tatjana Avšič-Županc; Katja Strašek Smrdel; Mateja Jelovšek; Stanka Lotrič-Furlan Journal: PLoS One Date: 2014-07-24 Impact factor: 3.240
Authors: Agnetha Hofhuis; Sita Bennema; Margriet Harms; Arnold J H van Vliet; Willem Takken; Cees C van den Wijngaard; Wilfrid van Pelt Journal: BMC Public Health Date: 2016-05-23 Impact factor: 3.295